Bob De Lange plans CAT share sale under Rule 144

Bob De Lange has filed a notice under Rule 144 indicating an intention to sell 12,507 shares of CAT common stock.

Rhea-AI Filing Summary

Bob De Lange has filed a notice under Rule 144 indicating an intention to sell 12,507 shares of CAT common stock. These shares were acquired on 02/11/2026 through a stock option exercise paid in cash, with Morgan Stanley Smith Barney LLC listed as broker and the shares traded on the NYSE.

The notice also lists prior sales of CAT common shares during the previous three months, including 22,656 shares sold on 02/06/2026, 16,070 shares on 02/04/2026, and 15,977 shares on 02/02/2026, with associated gross proceeds for each sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CAT Form 144 filing by Bob De Lange disclose?

The Form 144 discloses that Bob De Lange intends to sell 12,507 shares of CAT common stock. These shares were acquired via a cash-paid stock option exercise on 02/11/2026, with Morgan Stanley Smith Barney LLC as broker and trading on the NYSE.

How many CAT shares does Bob De Lange plan to sell under Rule 144?

Bob De Lange plans to sell 12,507 shares of CAT common stock under Rule 144. The filing shows these shares were acquired on 02/11/2026 through a stock option exercise, with the transaction designated as a cash payment acquisition.

What prior CAT share sales are reported for Bob De Lange in the last three months?

The filing reports three prior CAT common stock sales for Bob De Lange: 22,656 shares on 02/06/2026, 16,070 shares on 02/04/2026, and 15,977 shares on 02/02/2026. Each transaction includes listed gross proceeds in the Rule 144 notice.

How were the CAT shares in the planned Rule 144 sale acquired?

The 12,507 CAT common shares in the planned Rule 144 sale were acquired through a stock option exercise. The acquisition date is 02/11/2026, and the filing states the nature of payment for the option exercise was cash on that same date.

Which broker is handling Bob De Langes planned CAT share sale?

The planned sale of 12,507 CAT common shares is listed with Morgan Stanley Smith Barney LLC Executive Financial Services. The brokers address is given as 1 New York Plaza, 8th Floor, New York, NY 10004, and the filing names the NYSE as the exchange.

What is the aggregate market value for the CAT shares planned for sale?

The filing lists an aggregate market value of 9,593,885.82 for the 12,507 CAT common shares to be sold. This value is tied directly to the planned Rule 144 transaction and corresponds to the share amount specified in the securities information table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/11/2026 - 04:22 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001694342
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CATERPILLAR INC.
SEC File Number	001-00768
Address of Issuer	5205 N. O'CONNOR BOULEVARD, SUITE 100 IRVING TEXAS 75039
Phone	(972) 891-7700
Name of Person for Whose Account the Securities are To Be Sold	BOB DE LANGE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12507	9593885.82	467979596	02/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2026	Stock Option Exercise	Issuer			12507	02/11/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BOB DE LANGE 5205 N. O'CONNOR BOULEVARD, SUITE 100 IRVING TX 75039	Common	02/06/2026	22656	16314834.82
BOB DE LANGE 5205 N. O'CONNOR BOULEVARD, SUITE 100 IRVING TX 75039	Common	02/04/2026	16070	11328798.80
BOB DE LANGE 5205 N. O'CONNOR BOULEVARD, SUITE 100 IRVING TX 75039	Common	02/02/2026	15977	10912128.03

144: Remarks and Signature

Remarks
Date of Notice	02/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/S/ Bob De Lange
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)